Investigating the causes and treatments of inflammatory bowel diseases in veterans
Official title: BLRD Research Career Scientist Award Application
Funded at Kansas City VA Medical Center · NIH-11063227 · Data updated 2026-11-12
This study is looking into how inflammatory bowel diseases (IBD) affect veterans more than others, and it aims to find new ways to treat these conditions by exploring certain proteins and gut bacteria, which could lead to better treatments and fewer complications like colon cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kansas City VA Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| NIH project number | 5IK6BX006529-03 |
| Project ID | NIH-11063227 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans diagnosed with inflammatory bowel diseases.
✕Less likely to help
Patients who do not have inflammatory bowel diseases or are not veterans may not receive any benefit from this research.
What this research studies
This research focuses on understanding inflammatory bowel diseases (IBD), which are chronic conditions affecting the gut, particularly in veterans who are experiencing a higher incidence than the general population. The study aims to identify key molecular mechanisms and biomarkers associated with IBD to develop new therapeutic approaches. By analyzing the role of specific proteins and gut microbiota, the research seeks to improve treatment options and reduce the risk of complications such as colon cancer. Patients may benefit from novel therapies and better management of their condition.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and reduced complications for veterans suffering from inflammatory bowel diseases.
How similar studies have gone: Previous research has shown promise in identifying biomarkers and therapeutic targets for inflammatory bowel diseases, indicating that this approach has potential for success.
Where this research is happening
-
Kansas City VA Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Singh, Amar B — Kansas City VA Medical Center
- Study coordinator: Singh, Amar B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.